EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Sfrp2 in Microglia Inhibited S100a8-Mediated Neuroinflammation and Protected Neural Damage Following Retinal Ischemia-Reperfusion

Shuya Tao, Wen Hu, Yaguang Hu, Qiaochu Cheng, Zihao Lin, Hao Xu, Yuxun Shi, Dan Ye, Fan Xu, Yue Xu, Yantao Wei, Jingjing Huang

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.3.8 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Shuya Tao and 11 co-authors. Institution: Zhongshan Ophthalmic Center, Sun Yat-Sen University, WHO Collaborating Centre for Eye Care and Vision, State Key Laboratory of Ophthalmology, Guangdo…. Major MEDLINE topics: Reperfusion Injury, Microglia, Membrane Proteins, Calgranulin A. Cited 3 times so far (Crossref); 70 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

The purpose of this study was to explore retinal Sfrp2 expression, functional roles, and underlying mechanism in retinal ischemia reperfusion (I/R).

Methods

We established an I/R mouse model in vivo and a lipopolysaccharide-stimulated BV2 model in vitro. Immunohistochemistry and Western blotting (WB) assessed Sfrp2 expression in human retinal tissue, and WB further evaluated its expression in I/R model. Immunofluorescence staining was used to define its localization. Sfrp2 expression was ablated by Cre-lox mediated conditional deletion in mouse retinal microglia and by siRNA-mediated knockdown in BV2 cells. Hematoxylin and eosin staining, immunofluorescence, and TUNEL staining were applied for evaluating retinal structure, survival of inner retinal neurons, and cell apoptosis, respectively. Retinal function was evaluated by electroretinography. RNA-sequencing, WB, and immunoprecipitation were used to elucidate the underlying mechanisms.

Results

Sfrp2 was highly expressed in the retina subjected to I/R injury. Sfrp2 was shown to localize in microglia in an I/R model. Correspondingly, microglial Sfrp2 deficiency exacerbated the retinal structural damage, inner retinal neuronal degeneration, visual dysfunction, and microglia-mediated inflammation in the I/R model. Mechanistically, Sfrp2 deficiency activated TRAF6-TAK1-NF-κB signaling cascade by promoting the TRAF6-TAK1 complex formation, subsequently increasing the expression of downstream inflammatory mediator S100a8. Importantly, S100a8 inhibitor could partially mitigate the retinal injury induced by microglial Sfrp2 deficiency following I/R.

Conclusions

Sfrp2 in microglia inhibits TRAF6-TAK1-NF-κB signaling pathway and downstream inflammatory mediator S100a8 thereby attenuating neuroinflammation and protecting the retina in I/R. Sfrp2 may represent a protective strategy for neuronal degeneration in ischemic retinopathy.

Subjects

MeSH terms (MEDLINE)

Reperfusion InjuryMicrogliaMembrane ProteinsCalgranulin ANeuroinflammatory DiseasesRetinal DiseasesAnimalsMiceDisease Models, AnimalSecreted Frizzled-Related ProteinsMice, Inbred C57BLBlotting, WesternMaleHumansSignal TransductionTNF Receptor-Associated Factor 6ElectroretinographyImmunohistochemistryMAP Kinase Kinase Kinase 7NF-kappa BRetinal Ganglion CellsApoptosis

Substances

Secreted Frizzled-Related ProteinsSfrp2 protein, mouseMembrane ProteinsCalgranulin AS100a8 protein, mouseTNF Receptor-Associated Factor 6MAP Kinase Kinase Kinase 7TRAF6 protein, mouseNF-kappa B

Authors and institutions

  • Zhongshan Ophthalmic Center, Sun Yat-Sen University, WHO Collaborating Centre for Eye Care and Vision, State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guan…
  • Department of Ophthalmology, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Key Laboratory of Eye Health, Guangxi Health Commission Key Laboratory of Ophthalmology and Related Systemic Diseases Artif…
  • Department of Ophthalmology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.
  • Department of Ophthalmology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.

Cite

APA

Tao, S., Hu, W., Hu, Y., Cheng, Q., Lin, Z., Xu, H., Shi, Y., Ye, D., Xu, F., Xu, Y., Wei, Y., & Huang, J. (2026). Sfrp2 in Microglia Inhibited S100a8-Mediated Neuroinflammation and Protected Neural Damage Following Retinal Ischemia-Reperfusion. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.3.8

Vancouver

Tao S, Hu W, Hu Y, Cheng Q, Lin Z, Xu H, et al. Sfrp2 in Microglia Inhibited S100a8-Mediated Neuroinflammation and Protected Neural Damage Following Retinal Ischemia-Reperfusion. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.3.8

BibTeX
@article{Tao2026,
  author = {Tao, Shuya and Hu, Wen and Hu, Yaguang and Cheng, Qiaochu and Lin, Zihao and Xu, Hao and Shi, Yuxun and Ye, Dan and Xu, Fan and Xu, Yue and Wei, Yantao and Huang, Jingjing},
  title = {Sfrp2 in Microglia Inhibited S100a8-Mediated Neuroinflammation and Protected Neural Damage Following Retinal Ischemia-Reperfusion},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.3.8}
}
Start for free →